Article

Contact lens approved for use as bandage lens

A contact lens (Acuvue Oasis, Vistakon) has received FDA approval for therapeutic use as a bandage lens for certain acute and chronic ocular conditions.

Jacksonville, FL-A contact lens (Acuvue Oasis, Vistakon) has received FDA approval for therapeutic use as a bandage lens for certain acute and chronic ocular conditions.

"The wettability, smoothness, flexibility, high [level of] oxygen transmissibility, comfort, and Class I [ultraviolet light]-blocking properties of [the lens] make it an excellent choice for therapeutic use as a bandage lens for a range of conditions," said Sheila Hickson-Curran, director, medical affairs, Vistakon.

William B. Trattler, MD, a cornea specialist at the Center for Excellence in Eyecare, Miami, and a volunteer assistant professor at Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, said, "Under certain conditions, the use of a silicone hydrogel lens like [this lens] can help protect the cornea from exposure or repeated irritation often caused by rubbing during the wound-healing process and [can] assist in pain relief. For my patients, I have also found that [this lens] works wonderfully as a bandage contact lens for laser vision correction, as it reduces discomfort."

The recent FDA approval includes these uses:

The lens can be worn continuously for up to 6 nights and 7 days when used as a therapeutic lens. It also is indicated for daily wear vision correction and may be worn consecutively for up to 6 nights and 7 days of extended wear as recommended by an eye-care professional.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.